Yizhuo Zhang
Sun Yat-Sen University Cancer Center · SunYat Sen University Cancer Center · Sun Yat-sen University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yizhuo Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:47 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06836505 · Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.Sun Yat-Sen University Cancer Center · recruiting · Neuroblastoma (NB), Desmoplastic Small Round Cell Tumor (DSRCT) · principal investigator
- Ph1NCT06760117 · UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid TumorsSun Yat-sen University · recruiting · Pediatric Solid Tumor · principal investigator
- Ph1NCT06631391 · Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.Sun Yat-sen University · recruiting · Neuroblastoma · principal investigator
- Ph3NCT06208917 · Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in ChildrenYizhuo Zhang · recruiting · Pediatric Solid Tumor, Unspecified, Protocol Specific · principal investigator
- Ph2NCT06013618 · Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed NeuroblastomaSun Yat-Sen University Cancer Center · recruiting · Neuroblastoma · study chair
- N/ANCT05778955 · Study on Dynamic CtDNA Analysis in Pediatric Soft Tissue SarcomaSun Yat-sen University · unknown · Pediatric Soft Tissue Sarcoma · principal investigator
- Ph1/Ph2NCT05701306 · APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid TumorsAscentage Pharma Group Inc. · recruiting · Neuroblastoma, Solid Tumor · principal investigator
- Ph2NCT05457829 · Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical StudySun Yat-sen University · recruiting · Rhabdomyosarcoma, Child · principal investigator
- Ph1/Ph2NCT05027386 · Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.Sun Yat-sen University · completed · Neuroblastoma · principal investigator
- N/ANCT04957901 · The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical StudySun Yat-sen University · recruiting · Lymphoma · principal investigator
- N/ANCT04726995 · DLBCL Treatment in Children and AdolescentsSun Yat-sen University · completed · Diffuse Large B-cell Lymphoma · principal investigator
- Ph1NCT04659733 · Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in ChildrenYizhuo Zhang · unknown · Sarcoma · principal investigator
- Ph2NCT04581265 · Nab-PTX, Ifosfamide and Cisplatin in the Treatment of Pediatric Extracranial Germ Cell Tumor.Sun Yat-sen University · unknown · Extracranial Germ Cell Tumor, Pediatric · principal investigator
- Ph2NCT04547829 · Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After ChemotherapySun Yat-sen University · unknown · Pediatric Cancer · principal investigator
- Ph2NCT04508400 · Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric PatientsSun Yat-sen University · completed · Pediatric Cancer · principal investigator
- Ph1NCT04213612 · DCV in the Treatment of Recurrence and Refractory Childhood Solid TumorsSun Yat-sen University · unknown · Unrecognized Condition · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:47 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in rhabdomyosarcoma.